Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 7.620\% hERG inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. CC(C)CN1C(=O)/C(=C(/C#N)C(=O)NC2CCCCC2)c2ccccc21
b. CC(C)N(Cc1nccn1C)C(=O)CC1C(=O)NCCN1Cc1ccccc1C(F)(F)F
Answer: b. CC(C)N(Cc1nccn1C)C(=O)CC1C(=O)NCCN1Cc1ccccc1C(F)(F)F
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)N(Cc1nccn1C)C(=O)CC1C(=O)NCCN1Cc1ccccc1C(F)(F)F
CC(C)N(Cc1nccn1C)C(=O)CC1C(=O)NCCN1Cc1ccccc1C(F)(F)F
N-[(1-methylimidazol-2-yl)methyl]-2-[3-oxo-1-[[2-(trifluoromethyl)phenyl]methyl]piperazin-2-yl]-N-propan-2-ylacetamide